3Jordon JE,Zhao Z,Sato H,et al.Agents to improve cardiovascular circulation and cardiac metabolism-cinepazide[J].Circulation,1995,92(suppl 1):520-524.
4Gronstein BN.Adenosine,enendogenous ant inflammatory agent[J].JAPPL Phhysilol,1999,96(8):5-10.
二级参考文献10
1[1]Panza J A, Dilsizian V, Curiel R V, et al. Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol, 1999, 6:487-494.
2[2]Derek M, Gary F, Mark S, et al. Ischemic preconditioning: present position and future directions. Cardiovasc Res, 1998, 37:21-33.
3[3]Jong J, Jonge R, Keijzer E, et al. The role of adenosine in preconditioning. Pharmacol Ther, 2000, 87:141-149.
4[4]Kloner R A, Bolli R, Mardan E, et al. Medical and cellular implications of stunning, hibernation, and ischemic preconditioning. An NHLBI workshop. Circulation, 1998, 97:1848-1867.
5[5]McCully J D, Uematsu M, Parker R A, et al. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart. J Thorac Cardiovasc Surg, 1998, 116:154-162.
6[6]Higano S T, Lerman A, Garrat K N, et al. Assessing coronary flow physiology with intracoronary Doppler following coronary intervention. Interven Cardiol, 1996, 9:163-173.
7[7]Wei K, Ragosita M, Thorpe J, et al. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardigraph. Circulation, 2001, 103:2560-2565.
8[8]White C W. Clinical applications of Doppler coronary flow reserve measurement. Am J Cardiol, 1993, 71:10D-16D.
9[9]Yao S K, Ober J C, Gonenne A, et al. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ Res, 1993, 73:952-956.
